Bank of Montreal’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-484,069
Closed -$5.31M 4247
2023
Q4
$5.31M Sell
484,069
-326,381
-40% -$3.55M ﹤0.01% 1257
2023
Q3
$8.73M Sell
810,450
-106,008
-12% -$1.14M ﹤0.01% 1051
2023
Q2
$9.83M Buy
916,458
+105,961
+13% +$1.12M ﹤0.01% 1015
2023
Q1
$8.59M Buy
810,497
+660,497
+440% +$6.86M ﹤0.01% 997
2022
Q4
$1.54M Sell
150,000
-65,858
-31% -$668K ﹤0.01% 1920
2022
Q3
$2.17K Buy
+215,858
New +$2.16M ﹤0.01% 1768

Other funds holding RENE

Bank of Montreal's RENE Position: Q1 2024 in Review

Bank of Montreal sold out of Cartesian Growth Corp II (RENE) in Q1 2024, closing a stake of 484,069 shares — an estimated $5.31M sold.

Bank of Montreal first reported a position in RENE in Q3 2022 and held it in 6 quarters. The position peaked at $9.83M in Q2 2023. 33 funds tracked by Wall St. Rank hold RENE as of Q1 2024.

  • Bank of Montreal reported no remaining Cartesian Growth Corp II position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 484,069 Cartesian Growth Corp II shares in Q1 2024, an estimated $5.31M.
  • Bank of Montreal first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 6 quarters.
  • Bank of Montreal's Cartesian Growth Corp II position peaked at $9.83M in Q2 2023.
  • 33 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.